Patent · US Active

Compounds, compositions and methods for inhibiting CNKSR1

US10227356B2 · kind B2 · utility

0Cited by
8References
37Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 20, 2016
Grant dateMar 12, 2019
Priority date
Expiry dateApr 20, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds that inhibit CNKSR1, pharmaceutical compositions including compounds that inhibit CNKSR1 and methods of treating disease or disorders that respond to CNKSR1 inhibition are described herein. Additionally, methods of identifying inhibitors of CNKSR1 are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.